ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Beroni Acquires Majority Interest in PENAO americanpharmaceuticalreview
February 08, 2021Beroni Group has completed its majority acquisition of the Sydney-based anti-cancer drug development company, PENAO Pty Ltd. As a result of this acquisition, Beroni now owns 60% of PENAO Pty Ltd’s shares.
Pharma Sources Insight January 2025
